To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects
Clinical trial NCT04018313 · COMPLETED
Trial details
- NCT number
- NCT04018313
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2021-03-27
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.